Healthcare M&A Leader Well-established nationwide M&A advisory with extensive deal history in healthcare, presenting recurring opportunities for sell-side engagements, buy-side advisory, and financing solutions across multiple healthcare sub-sectors.

Active Deal Volume Over one billion dollars in active sell-side and buy-side engagements signals substantial deal flow and potential cross-sell of valuation services, financing (including term loans, AR lending, mezzanine, SBA), and real estate loans to buyers and sellers.

Strong Industry Reach Focused expertise across Home Health, Hospice, Private Duty, Behavioral Health, IDD, Medical Staffing, Long Term Care, Urgent Care, and Pharmacy creates ripe opportunity to partner with adjacent healthcare providers and ancillary service buyers for tailored advisory and financing packages.

Financial Signal Revenue in the mid to high tens of millions with a broad client network and awards recognition (Pharmacy500, RXinsider, Axial Advisor 100) enhances credibility for engaging larger buyers and lenders, enabling credibility-based outreach and premium deal value discussions.

Growth & Networking Extensive buyer network (over 100,000 subscribers) and ongoing market visibility suggest opportunities to expand marketing partnerships, co-hosted events, and targeted outreach to finance providers, pharma distributors, and healthcare operators exploring strategic acquisitions.